Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial.
- DOI
- 10.1002/acr2.70097
- Published
- 2025 Oct
- Container
- ACR open rheumatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/acr2.70097,
title = {Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial.},
author = {Ruperto N and Lovell DJ and Synoverska O and Abud-Mendoza C and Spindler A and Vyzhga Y and Reyhan I and Grebenkina L and Tirosh I and Imundo L and Chiraseveenuprapund P and Kingsbury DJ and Sozeri B and Vora SS and Prahalad S and Zholobova E and Roberts KD and Sawyerr G and Blum A and Shapiro A and Diehl A and Ebrahim A and Klaus P and Martini A and Brunner HI and Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)},
year = {2025},
journal = {ACR open rheumatology},
doi = {10.1002/acr2.70097},
url = {https://doi.org/10.1002/acr2.70097}
}RIS
TY - JOUR TI - Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial. AU - Ruperto N AU - Lovell DJ AU - Synoverska O AU - Abud-Mendoza C AU - Spindler A AU - Vyzhga Y AU - Reyhan I AU - Grebenkina L AU - Tirosh I AU - Imundo L AU - Chiraseveenuprapund P AU - Kingsbury DJ AU - Sozeri B AU - Vora SS AU - Prahalad S AU - Zholobova E AU - Roberts KD AU - Sawyerr G AU - Blum A AU - Shapiro A AU - Diehl A AU - Ebrahim A AU - Klaus P AU - Martini A AU - Brunner HI AU - Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG) PY - 2025 JO - ACR open rheumatology DO - 10.1002/acr2.70097 UR - https://doi.org/10.1002/acr2.70097 ER -
APA
N, R., DJ, L., O, S., C, A., A, S., Y, V., I, R., L, G., I, T., L, I., P, C., DJ, K., B, S., SS, V., S, P., E, Z., KD, R., G, S., A, B., A, S., A, D., A, E., P, K., A, M., HI, B., & (PRCSG), P. R. I. T. O. (. A. T. P. R. C. S. G. (2025). Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial.. ACR open rheumatology. https://doi.org/10.1002/acr2.70097
Source records
- pubmed · retrieved 2026-09-27T01:06:18.624Z